Market cap
$419.9B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-22
Alerts
8
Price$89.34 +9.81% 3M daily closessample
90.6280.99
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 22SEC
- Oct 19SEC
- Oct 12INS
- Oct 01SEC
- Sep 25INS
- Sep 16SEC
- Sep 10INS
- Sep 04INS
Company facts
SEC EDGAR registration- Name
- Silexion Therapeutics Corp
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- -40sample, -100 to +100
- Reporting currency
- USD
Who is positioning in SLXN
sample- Insiders
- 10 insider transactions over 90 days, net selling, $266.8M
- Congress
- No member trades over 90 days
- Institutions · 13F
- 12 funds hold $6.0B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$26.6B +17.3% y/y
Q4 2024Q3 2026
Inventory$15.5B +15.2% y/y
Q4 2024Q3 2026
Accounts receivable$11.5B +8.7% y/y
Q4 2024Q3 2026
Total debt$32.1B +17.8% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $281.4B -9.6% 3M
- Sample peer B
- $107.0B -0.2% 3M
- Sample peer C
- $161.1B +10.6% 3M
- Sample peer D
- $67.0B +7.0% 3M
- Sample peer E
- $159.4B +13.7% 3M